There is some earlier evidence of a borderline significant LDL-cholesterol raising effect of DHA in APOE4 carriers in those with modest hypertrigylceridaemia [ 71 ] which was not evident in later studies in normolipdaemic individuals [ 67 ] or using more moderate intervention doses [ 68 ].
← all excerpts
Impact of Genotype on EPA and DHA Status and Responsiveness to Increased Intakes.
1
—
—